Court of Appeal · Decided 1 December 2022
Roszaidi bin Osman v Public Prosecutor
Feedback & support[2022] SGCA 75 · Case no. Criminal Appeal No 2 of 2019
✱ What happened, in plain English
There is no plain-English summary of this judgment yet.
Ask about this judgment →Laws this judgment relies on
Grounds of decision
Official text from eLitigation
Introduction
- [1]
[1] The accused, Mr Roszaidi bin Osman (“Roszaidi”), was charged with trafficking in a controlled drug under s 5(1)(a) of the Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“the MDA”) by handing two packets containing not less than 32.54g of diamorphine (“the Drugs”) to his wife, Ms Azidah binte Zainal (“Azidah”). Roszaidi was convicted by a judge of the General Division of the High Court (“the Judge”) and accordingly sentenced to death. His conviction was upheld by this court in Mohammad Azli bin Mohammad Salleh v Public Prosecutor and another appeal and other matters [2020] 1 SLR 1374 (“Azli”). In his appeal against his sentence, however, Roszaidi sought to have his capital sentence reduced to imprisonment for life under the alternative sentencing regime in s 33B(1)(b) of the MDA. When the matter was remitted to the Judge, the Judge held that Roszaidi was not eligible for the alternative sentencing regime (see Public Prosecutor v Roszaidi bin Osman [2021] SGHC 22 (“the Remittal Judgment”)). This is Roszaidi’s appeal against the Judge’s decision.
- [3]
[3] It is not in dispute between the parties that the First Limb is satisfied as Roszaidi was suffering from major depressive disorder (“MDD”) and substance use disorder (“SUD”) at the material time. This was also common ground between the two psychiatric experts who examined Roszaidi and gave expert evidence in the proceedings, namely: the Prosecution’s expert, Dr Bharat Saluja (“Dr Saluja”), and the Defence’s expert, Dr Jacob Rajesh (“Dr Rajesh”). The issues in this appeal therefore pertain only to the Second and Third Limbs of the Nagaenthran test.
- [4]
[4] In our judgment, both the Second Limb and the Third Limb are satisfied in Roszaidi’s case. The Second Limb is satisfied by Roszaidi’s MDD and his SUD, which operated together in a “synergistic” manner at the time of the offence (a term used by Dr Rajesh, which is explained at [39] and [69] below). As for the Third Limb, we are satisfied that Roszaidi’s mental responsibility for his acts and omissions in relation to his offence was indeed substantially impaired by the combination of his MDD and SUD at the material time. We set out the applicable legal principles and explain our reasons in full below. Where relevant, we also make reference to the dissenting judgment of Andrew Phang Boon Leong JCA and Steven Chong JCA (“the Minority Judgment”).
Facts
Roszaidi’s drug consumption from a young age
- [6]
[6] Roszaidi’s exposure to drugs began very early in his life. He started consuming cannabis at the young age of 10 with his friends, using the money given to him by his mother and grandmother for buying food, to buy cannabis instead.
- [7]
[7] The age at which Roszaidi began consuming other drugs is not consistently recorded in the experts’ reports. Dr Saluja’s first report dated 13 November 2015 (“Dr Saluja’s 1st Report”) recorded that Roszaidi began consuming heroin, erimin and dormicum from the age of 17. In contrast, Dr Rajesh’s second report dated 27 February 2020 (“Dr Rajesh’s 2nd Report”) records that Roszaidi started using heroin when he was just 12 years old; his father was a regular heroin user, and he would smoke heroin taken from his father’s stocks at home. He smoked heroin about three times a week with his friends. Dr Rajesh also records that Roszaidi started consuming erimin and dormicum tablets from the age of 12, and he consumed these once or twice a week. However, nothing turns on this difference because on either account, it is clear that Roszaidi was a heavy user of drugs from a young age.
Roszaidi’s drug-related treatments and criminal records
- [8]
[8] A perusal of Roszaidi’s treatment records at the Drug Rehabilitation Centre (“DRC”) and his criminal records reveals that he was subsequently plagued by drug-related problems for most of his adult life. These criminal records were tendered by the Prosecution on 26 April 2022, upon our request and without objection from either party.
- [12]
[12] On 23 February 2000, when Roszaidi was around 28 years old, he was convicted on another charge of unauthorised possession of a controlled drug (morphine), as well as a charge of smoking, self-administering or consuming morphine. For these two offences, he was sentenced to two years’ imprisonment and five years and three weeks’ imprisonment respectively, both to run concurrently. A further charge of consumption of cannabinol derivatives was taken into consideration.
- [13]
[13] On 28 July 2003, when Roszaidi was around 31 years old, he was placed under drug supervision for 24 months for his consumption of morphine. In 2006, when Roszaidi was around 34 years old, he stopped injecting heroin when he had to undergo an operation. He went to the Institute of Mental Health (“IMH”)’s addiction department for the “Subutex” (or buprenorphine) programme. However, even then, he continued to smoke heroin regularly. The longest period for which Roszaidi had held a job until this point was three years from 2003 to 2006, when he was between the ages of 31 and 34. During this time, he worked as a Production Officer in Jurong Island.
- [14]
[14] On 2 February 2007, when Roszaidi was around 35 years old, he was convicted of trafficking in a controlled drug (buprenorphine) and sentenced to five years’ imprisonment with five strokes of the cane. He was also convicted of smoking, self-administering or consuming buprenorphine and was sentenced to seven years and six months’ imprisonment with six strokes of the cane. These two sentences ran concurrently. Two further charges were taken into consideration: one charge of trafficking in buprenorphine, and one charge of smoking, self-administering or consuming buprenorphine. It is likely that it was when Roszaidi was serving this imprisonment term that he became acquainted with one “Is Cangeh”. In Roszaidi’s third long statement dated 17 October 2015 (“Roszaidi’s 3rd Long Statement”), he stated that he “saw [Is Cangeh] in prison when [he] was serving [the] sentence for [his] Subutex trafficking offence”.
- [15]
[15] After his release from prison in 2011, Dr Rajesh’s 2nd Report records that Roszaidi “stayed away from drugs for 1 year until 2012, when he was arrested for possession of heroin”. It is likely that this period of abstinence from drugs in fact ended before the end of 2011, given that – on 3 December 2011, when Roszaidi was around 39 years old – he was placed under drug supervision for 24 months for his consumption of buprenorphine. Some months later, on 24 August 2012 (when Roszaidi was around 40 years old), he was convicted on a charge of being in unauthorised possession of diamorphine and was sentenced to three years’ imprisonment.
- [16]
[16] In 2014, while Roszaidi was in prison, his father passed away.
Events occurring after Roszaidi’s release from prison in 2014
- [17]
[17] Sometime in 2014, when Roszaidi was around 42 years old, he was released from prison. Thereafter, he worked at a chemical company for a few months under the prison’s Work Release Scheme. Sometime in 2015, Roszaidi changed jobs and began working at a flour company. While the date of this change in employment cannot be ascertained with precision based on the materials presently before us, it can be surmised that he began working at the flour company in November or December 2014 or in early 2015, given that he stated that he had worked for the company that had contracted him out to the flour company for “nearly 6 months”, and he quit this job in May 2015.
- [18]
[18] It is not clear precisely when Roszaidi began consuming drugs again after his release from prison in 2014. Dr Saluja’s 1st Report records that Roszaidi’s longest period of remaining drug-free in the community (meaning other than when he was in prison) was for about one and a half years prior to his last relapse. This would have brought him to about five months before his arrest in October 2015 for the offence with which we are presently concerned. Based on this, Roszaidi would have resumed consuming drugs in or around May 2015. Dr Rajesh’s 2nd Report corroborates this to the extent that it records that Roszaidi’s longest period of abstinence from drugs was “slightly more than a year after his release from prison in 2014”, but differs from Dr Saluja’s account in stating that Roszaidi relapsed into drug use around February 2015 when he resumed smoking heroin, and that it was the escalation of his drug use which took place in May 2015 following the passing of his mother and grandmother.
- [19]
[19] Notwithstanding this point of uncertainty, it can be taken that Roszaidi largely abstained from consuming drugs for a year or more immediately after his release from prison in 2014, but either resumed or escalated his drug consumption in May 2015. In May 2015, Roszaidi suffered two bereavements: his grandmother passed away, and his mother passed away two weeks later. Roszaidi’s grandmother and mother had raised him, and he lived with them at the time of their passing. It is possible that he resumed his drug consumption earlier, in February 2015, a few months before they passed. However, in this connection, it bears highlighting that prior to the passing of Roszaidi’s mother, it seems that she suffered from a period of serious illness. It was noted in Dr Rajesh’s 2nd Report that Roszaidi’s mother “used to have regular dialysis for her kidney issues prior to her passing away” from kidney failure.
- [20]
[20] Shortly after these bereavements, Roszaidi quit his job at the flour company. Both experts diagnosed that Roszaidi started to suffer from depression at or around this time. Indeed, it is uncontested that the bereavements triggered his MDD. Dr Saluja’s 1st Report noted that Roszaidi had been depressed since around April or May 2015 and that his depression was “triggered by” the death of his mother and his grandmother, while Dr Rajesh’s 2nd Report opined that the “onset” of Roszaidi’s MDD was in May 2015 after these bereavements. After Roszaidi suffered these bereavements, his rate of drug consumption (of heroin, methamphetamine and dormicum) escalated. Importantly, although only Dr Rajesh recorded this as an escalation (in his 2nd Report), the fact of this escalation in May 2015 is common ground between the experts in so far as Dr Saluja’s 1st Report recorded that Roszaidi’s drug consumption resumed in May 2015, which in turn would necessarily have entailed an even sharper escalation in his rate of consumption from a base of no consumption. Roszaidi also stated that he resumed smoking cannabis in May 2015 and would then smoke cannabis whenever he felt like it.
- [21]
[21] In July 2015, Roszaidi began delivering drugs for Is Cangeh. From that point until his arrest, he completed five or six jobs for Is Cangeh. He told Dr Saluja that he “never bought heroin” because he “never had money to buy for [him]self (for [the] last 5 months)”. Instead, as he explained in his second long statement dated 16 October 2015 (“Roszaidi’s 2nd Long Statement”) and in his testimony at trial, he took various drugs from the consignments that he delivered for Is Cangeh for his personal consumption and to feed his drug addiction. This was corroborated by Dr Rajesh, both in his third report dated 31 August 2020 (“Dr Rajesh’s 3rd Report”) and in his testimony at the remittal hearing. It was not disputed that Roszaidi did not have the means to afford his escalating drug consumption after the onset of his MDD and that he obtained his supply (or at least a significant part thereof) from the drugs he was to deliver for Is Cangeh.
Circumstances surrounding the commission of the offence
- [22]
[22] On 6 October 2015, at or around noon, Roszaidi was shopping at the Jurong Point shopping mall (“Jurong Point”) with Azidah and their daughter. He had brought with him a red pouch containing a packet of heroin and approximately 50g of ice, as well as utensils for smoking both. He went into a toilet to smoke some of the heroin for about half an hour while Azidah and their daughter were elsewhere in Jurong Point. While he was at Jurong Point, Roszaidi received a call from Is Cangeh who told him to stand by for a job later that day.
- [23]
[23] Roszaidi left Jurong Point with Azidah and their daughter at around 2.00pm. They then travelled to his younger brother’s house, where they spent time with Roszaidi’s younger brother and his family. At around 6.00pm, Roszaidi received a further call from Is Cangeh instructing him to go to Jurong West Avenue 2, locate a lorry with a “Tiong Nam” logo and collect the Drugs. Roszaidi then called his friend, one Mr Mohammad Azli bin Mohammad Salleh (“Azli”), to pick him up and drive him around for the job, as he had done on previous occasions.
- [24]
[24] Sometime before 7.00pm that evening, Azli picked Roszaidi up from his younger brother’s house and Roszaidi told Azidah that he needed to “go out for a while”. Roszaidi told Azli to drive to Jurong West Avenue 2. While inside the car with Azli, Roszaidi smoked heroin for the second time that day. On the way to their destination, one Mr Muhammad Mirwazy bin Adam (“Mirwazy”) called Roszaidi asking for some methamphetamine. Roszaidi arranged to pick Mirwazy up from the Pioneer MRT station on the way to Jurong West Avenue 2. After picking Mirwazy up, Roszaidi and Mirwazy took turns to smoke methamphetamine inside Azli’s car. Roszaidi himself smoked “more than 10 puffs” of methamphetamine.
- [25]
[25] Sometime after 7.00pm, Roszaidi, Azli and Mirwazy arrived at Jurong West Avenue 2. While looking out for the lorry with the “Tiong Nam” logo, Roszaidi received a call from “someone”, not Is Cangeh, instructing him to go to the Shell petrol station beside Jurong Point. The group did so, only for Roszaidi to later be told by Is Cangeh to return to their previous location. The group duly did so and, there, they found the lorry in question. After confirming with Is Cangeh that this indeed was the vehicle from which the drugs were to be collected, Roszaidi told Is Cangeh to tell the lorry driver to “drive forward a bit”. The lorry then drove past Azli’s car and Roszaidi told Azli to follow it. The group followed the lorry for some distance before both vehicles stopped. Roszaidi then alighted from Azli’s car and collected two packets of diamorphine (ie, the Drugs) and three packets of methamphetamine in a red plastic bag from one Mr Aishamudin bin Jamaludin (“Aishamudin”) and one Mr Suhaizam bin Khariri (“Suhaizam”), who were waiting in the cabin of the lorry. For the avoidance of doubt, as the offence that Roszaidi was convicted of only involves the two packets of diamorphine, any reference in this judgment to “the Drugs” should be understood to refer only to the diamorphine. While it is not clear precisely what time the collection of the Drugs took place, it seems this would have been around or shortly after 9.30pm.
- [26]
[26] After returning to the car and inspecting the consignment of drugs he had just collected, Roszaidi realised that the drugs seemed of a larger quantity than he expected, and he called Is Cangeh to ask why there was so much heroin and ice in the consignment (“the Phone Call”). Is Cangeh told him to hold on to the drugs for a while and to complete the delivery.
- [27]
[27] Roszaidi then directed Azli to drive off and they dropped Mirwazy off at the JCube shopping mall. After waiting for some time for a call from the person to whom he was meant to deliver the drug consignment, Roszaidi decided to call Azidah, who was still at Roszaidi’s younger brother’s house with their daughter. Roszaidi told Azidah that he needed her to “come down to take something” from him, without telling her that he was handing her drugs, and told her to bring along a plastic bag. Roszaidi then told Azli to drive to Jurong West Street 91, where Azidah would be waiting. On the way there, Roszaidi removed the Drugs and two of the packets of methamphetamine from the red plastic bag and placed them in a “Starmart” plastic bag. When Roszaidi and Azli reached Jurong West Street 91, Azidah was waiting along the road with a yellow paper bag. Roszaidi wound down the car window, took the yellow paper bag from Azidah, placed the “Starmart” plastic bag inside the yellow paper bag, and handed it back to her through the car window. This took place at around 10.22pm. This transfer of the Drugs to Azidah forms the actus reus of the drug trafficking offence of which Roszaidi was convicted.
- [28]
[28] Azidah then returned to Roszaidi’s younger brother’s house, while Roszaidi and Azli drove off. Shortly thereafter, Roszaidi, Azli and Azidah were arrested by Central Narcotics Bureau (“CNB”) officers. At the time of his arrest, Roszaidi was 43 years old.
Procedural history
- [29]
[29] The procedural history of this matter has been outlined in broad strokes at the outset of our judgment. However, we set this out in further detail here because this has a bearing on how arguments were developed, and evidence was adduced, in these proceedings.
- [30]
[30] Roszaidi was convicted by the Judge of drug trafficking under s 5(1)(a) of the MDA on 21 January 2019. As the issue of whether Roszaidi qualified for the alternative sentencing regime in s 33B(1)(b) of the MDA was not raised at trial, the Judge sentenced him to the mandatory death penalty pursuant to s 33 of the MDA (see the Remittal Judgment at [1]; see also Azli at [25] and [34]).
- [31]
[31] On 25 January 2019, Roszaidi filed his Notice of Appeal against both conviction and sentence in Criminal Appeal No 2 of 2019 (“CCA 2/2019”). This appeal, together with Azli’s appeal against his conviction and sentence, formed the subject of our judgment in Azli. Before the appeals were heard, on 26 August 2019, Roszaidi filed Criminal Motion No 17 of 2019 (“CM 17”) seeking leave to rely on a further ground in his appeal against his sentence – namely, that he was eligible for the alternative sentencing regime under s 33B(1)(b) and should therefore be re-sentenced to life imprisonment.
- [32]
[32] After CM 17 was filed, but prior to the hearing of the appeals, we directed the parties to adduce additional evidence in the form of psychiatric reports (based only on the existing evidence and medical notes) addressing each of the three limbs of the Nagaenthran test (see Azli at [35]). We did so because the court considered at the time that the evidence that would have been relevant for the consideration of the issues under s 33B(3) – and in particular, the psychiatric evidence which would be crucial under s 33B(3)(b) – was “uneven to say the least” (see Azli at [25]). That observation as to the state of the evidence pertaining to the three limbs of the Nagaenthran test was not surprising simply because that issue had not been live at the trial. Dr Saluja, who was the only witness to give expert evidence on Roszaidi’s mental state, had not been directed to this issue at all. In response to our directions that further evidence be adduced, Dr Saluja produced his second report dated 10 October 2019 (“Dr Saluja’s 2nd Report”), his third report dated 1 November 2019 (“Dr Saluja’s 3rd Report”) and his fourth report dated 19 November 2019 (“Dr Saluja’s 4th Report”). Roszaidi was also given leave to tender an expert report in reply and this led to the production of Dr Rajesh’s first report dated 16 December 2019 (“Dr Rajesh’s 1st Report”). Dr Saluja then tendered his fifth report, dated 14 January 2020 (“Dr Saluja’s 5th Report”), in reply to Dr Rajesh’s 1st Report (see Azli at [36]–[38]).
- [34]
[34] We heard the appeals on 17 February 2020. On 23 April 2020, we dismissed Roszaidi’s appeal against conviction (see Azli at [11]–[20]). However, as regards Roszaidi’s appeal against sentence, we observed that the various psychiatric reports produced by Dr Saluja and Dr Rajesh revealed a disagreement between the two experts as to whether and how the Second and Third Limbs of the Nagaenthran test were or could be satisfied, for the purposes of the alternative sentencing regime in s 33B of the MDA. We concluded that it would not have been satisfactory to have decided this aspect of Roszaidi’s appeal given the state of the evidence then before us. In short, we were satisfied that the matter warranted a closer look and we therefore allowed CM 17 and remitted the matter to the Judge for additional evidence to be taken pursuant to s 392(1) of the Criminal Procedure Code (Cap 68, 2012 Rev Ed) (“the CPC”) on the following questions, which correspond to the three limbs of the Nagaenthran test (see Azli at [39]–[40]):
- [35]
[35] We also directed the Defence to obtain a further report from Dr Rajesh taking into account his interviews with Roszaidi (see Azli at [41]). This led to the production of Dr Rajesh’s 2nd Report (dated 27 February 2020) and Dr Rajesh’s 3rd Report (dated 31 August 2020). Both experts also gave oral evidence at the remittal hearing before the Judge on 12 October 2020.
- [36]
[36] We digress momentarily to observe that the Minority Judgment takes substantial issue with the fact that Roszaidi did not raise the issue of re-sentencing at trial or at least earlier in these proceedings. Indeed, this constitutes an important framing device through which the minority suggests the present appeal should be examined, and which seems to contribute to its conclusion that Roszaidi generally failed to adduce sufficient evidence to avail himself of s 33B(3)(b) of the MDA (see the Minority Judgment at [239]–[244]). With respect, we cannot agree, for reasons that are canvassed more fully later in this judgment. Having disposed of CM 17 as we did, and having allowed the further evidence to be adduced, it would be inappropriate to then hold it against Roszaidi that the issue was not raised earlier. We therefore consider all of the evidence on the footing that it was appropriately raised and is not to be disregarded or even discounted for not having been raised at the trial. In our judgment, any other approach would improperly undermine the orders we made in disposing of CM 17 as we did.
- [37]
[37] Having regard to the further evidence adduced on the remitted questions, the Judge held on 1 February 2021 that Roszaidi did not satisfy the requirements in s 33B(3)(b) and consequently could not avail himself of the alternative sentencing regime in s 33B(1)(b) of the MDA.
Decision below
- [38]
[38] We now summarise the Judge’s reasoning in the Remittal Judgment.
- [39]
[39] The Judge first noted that Dr Saluja and Dr Rajesh agreed that Roszaidi suffered from two recognised mental disorders at the time of his commission of the offence – MDD and SUD – and that it was undisputed that both disorders were “abnormalities of mind” for the purposes of the First Limb of the Nagaenthran test (see the Remittal Judgment at [7]). The Judge also noted that both experts agreed that Roszaidi’s MDD was an abnormality of mind that arose from an inherent cause, and accordingly found that the Second Limb was satisfied in so far as Roszaidi’s MDD was concerned (see the Remittal Judgment at [8]). However, the Judge found that there was nothing to show that Roszaidi’s SUD had arisen from any inherent cause, rejecting Dr Rajesh’s opinion that Roszaidi’s MDD had formed the “underlying substrate” for his SUD and that the two conditions had operated in a “synergistic” manner (which we refer to as Dr Rajesh’s “Synergy Claim”). The Judge therefore concluded that Roszaidi’s SUD did not satisfy the Second Limb (see the Remittal Judgment at [8]–[9]).
- [40]
[40] As only Roszaidi’s MDD satisfied the First and Second Limbs of the Nagaenthran test, the question considered by the Judge at the Third Limb was whether Roszaidi’s MDD had substantially impaired his mental responsibility for his acts and omissions in relation to his offence. The Judge answered this question in the negative. Here, as in his analysis of the Second Limb, the Judge preferred Dr Saluja’s evidence and rejected Dr Rajesh’s. The Judge took the view that Roszaidi had made a “reasoned choice” and “conscious decision” to continue trafficking for Is Cangeh because he believed that its risks were outweighed by its rewards. The Judge also held that Roszaidi’s ability to execute the tasks that Is Cangeh required of him evidenced his ability to think in a “logical and organised manner”. Accordingly, the Judge concluded that there was insufficient evidence to show that Roszaidi's MDD had substantially impaired his mental responsibility (see the Remittal Judgment at [12], [19] and [21]).
The parties’ cases on appeal
- [41]
[41] In respect of the Second Limb, the parties disagree only on whether Roszaidi’s SUD satisfies this limb. Roszaidi’s case before the Judge was premised on Dr Rajesh’s Synergy Claim: that his SUD and MDD operated together in a “synergistic” manner to exacerbate his overall mental state, and that his MDD was the “underlying substrate” for his escalating drug abuse. In other words, given that both experts accepted that his MDD arose from an inherent cause, and given that his escalating drug abuse flowed from his MDD, Roszaidi argues that his SUD similarly arose from an inherent cause. In his oral submissions before us, counsel for Roszaidi, Mr Eugene Thuraisingam (“Mr Thuraisingam”), maintained the same position. Roszaidi’s written submissions also emphasised that SUD is a recognised psychiatric condition, and that Roszaidi’s substantial and long-term drug use wrought permanent damage on his mind such that the mental abnormalities attendant upon SUD arose from an inherent cause. This stands in contrast with the effects of temporary and self-induced drug intoxication, which Roszaidi acknowledges would clearly not satisfy the Second Limb. For similar reasons, Roszaidi argued in his written submissions that his SUD could also have been said to have been induced by disease or injury.
- [42]
[42] In response, the Prosecution relies on Dr Saluja’s assessment that Roszaidi’s SUD did not arise from any of the prescribed aetiologies under the Second Limb. The Prosecution challenges Dr Rajesh’s Synergy Claim on the ground that Roszaidi’s history of substance abuse began long before he started exhibiting symptoms of MDD, and that his SUD therefore arose prior to and independently from his MDD. The Prosecution further submits that Roszaidi’s MDD was unlikely to have added to his inability to resist drug-seeking behaviour. However, the Deputy Public Prosecutor, Mr Hay Hung Chun (“Mr Hay”), acknowledged in his oral submissions that Dr Saluja had not identified a reason for his conclusion that Roszaidi’s SUD allegedly failed to satisfy the Second Limb. We digress to observe that on this basis alone, Dr Saluja’s evidence on this issue should be viewed with considerable anxiety.
- [43]
[43] In respect of the Third Limb, Roszaidi submits that the “significant” abnormality of mind that substantially impaired his mental responsibility was his reduced willpower to resist taking drugs, due largely to his SUD which in turn was exacerbated by his MDD. He argues that the combined effect of his MDD and SUD so substantially undermined his ability to resist drug-taking that it compelled him to continue trafficking in drugs to feed his own addiction. Roszaidi additionally maintains his submission below that his rational judgment was impaired at the time of the offence. He argues that such impairment is evidenced by: (a) his panic, fear and confusion at the material time; (b) his irrational decision to implicate his innocent wife by passing the Drugs to her while he tried to decide what to do next; and (c) the fact that he was under the influence of drugs at the time of the offence, which would have exacerbated his impaired judgment arising from his MDD and/or SUD.
- [44]
[44] The Prosecution’s written submissions concentrate on the issue of whether Roszaidi’s rational judgment was impaired at the material time. The Prosecution argues that Roszaidi retained higher-level cognitive abilities at the time of the offence, including the ability to plan, organise and coordinate things between different people. The Prosecution further argues that Roszaidi did not exhibit any significant change in behaviour compared to previous instances of offending (when there was no evidence that he had MDD), and indeed exercised rational judgment to act in a “consistently goal-oriented manner” before, during and after the commission of the offence. This submission was based on Dr Saluja’s observation that Roszaidi had consumed and trafficked in drugs in the past before the onset of his MDD. The Prosecution therefore submits that Roszaidi’s MDD did not contribute to his commission of the offence, and that at all material times, Roszaidi was “more than capable of assessing the risks and rewards involved in the criminal act he intended to undertake, reason out his decision, and carry out his plan”.
- [45]
[45] In his oral submissions, Mr Hay also argued that Roszaidi’s impulse control was not sufficiently impaired so as to fulfil the Third Limb. Mr Hay stressed that: (a) Dr Saluja had diagnosed Roszaidi’s MDD to be “on the lowest [end of the] spectrum”; (b) Roszaidi was able to direct operations in picking up the drugs on the day of the offence; and (c) Roszaidi had the presence of mind to hand over the Drugs to Azidah for safekeeping because he thought it was dangerous for him to carry them around. Mr Hay submitted that these were indicators that Roszaidi’s MDD was “not affecting him such that it could be said that it substantially impaired his responsibilities for his act”.
Issues to be determined
- [46]
[46] In these circumstances, two broad issues arise for our determination in this appeal:
(a) First, whether the Second Limb of the Nagaenthran test is satisfied by Roszaidi’s MDD and his SUD operating together.
(b) Second, whether the relevant abnormalities of mind substantially impaired Roszaidi’s mental responsibility for his acts and omissions in relation to his offence, such that the Third Limb of the Nagaenthran test is satisfied.
- [47]
[47] Before we turn to address each of these issues, we first set out our general observations regarding the expert evidence adduced by Dr Saluja and Dr Rajesh. This expert evidence, as will be seen, assumed considerable importance in the present case.
General observations on the expert evidence
- [48]
[48] Both the Judge’s decision and the Prosecution’s case are premised on a reliance on Dr Saluja’s views and a rejection of those of Dr Rajesh. The Minority Judgment also makes much of Dr Saluja’s 1st Report, which it regards as “crucial” (see the Minority Judgment at [205] and [220]) and, indeed, “the key” report [emphasis in original] (see the Minority Judgment at [227]). In our judgment, this fails to consider the serious shortcomings of Dr Saluja’s expert evidence and, consequently, its limited utility in assisting this court with answering the questions before us in this appeal.
- [49]
[49] We begin with Dr Saluja’s 1st Report. It is important to bear in mind precisely when and for what purpose this report was prepared, having regard to the relevant procedural history, which we have recounted above. Dr Saluja’s 1st Report, dated 13 November 2015, was prepared with reference to (among other sources of information) his interviews with Roszaidi on 26 and 27 October 2015 and 11 November 2015, shortly after Roszaidi’s arrest on 6 October 2015, as well as other contemporaneous medical notes and reports. Dr Saluja’s original terms of reference are not in the record, but based on the medical opinion and recommendations he gave in this report, Dr Saluja’s initial assessment appears to have been focused on addressing three points: diagnosing Roszaidi with SUD and MDD; ascertaining that Roszaidi was not of unsound mind and that his depressive symptoms were not a contributory factor to the alleged offence; and determining that Roszaidi was fit to plead.
- [50]
[50] Dr Saluja’s 1st Report was prepared for the purposes of Roszaidi’s trial before the Judge, long before the issue of re-sentencing under s 33B(1)(b) of the MDA was raised in CM 17. At the time this report was prepared, the question of whether Roszaidi satisfied the conditions for the alternative sentencing regime was not yet in issue (see also [30]–[31] above), and it was directed at addressing a different set of issues from those relevant to s 33B(3)(b) of the MDA. Consequently, Dr Saluja’s 1st Report would not, and indeed could not, have considered and addressed the specific issues that were relevant to the remittal and, in particular, the crucial questions before us of whether Roszaidi’s mental responsibility was substantially impaired by his abnormalities of mind arising from the prescribed aetiologies. Here, a distinction therefore needs to be drawn between the factual reliability of Dr Saluja’s 1st Report, in terms of recording the background facts that were told to him by Roszaidi in the aftermath of his arrest, and the analytical weight that should be accorded to its conclusions. The fact that Dr Saluja’s 1st Report was prepared with reference to his contemporaneous interviews with Roszaidi shortly after his arrest might mean that it recorded more candid responses from Roszaidi regarding matters such as his drug consumption history. But this does not mean that Dr Saluja’s assessment of whether Roszaidi's mental responsibility was substantially impaired at the material time should also be accorded greater weight on this ground (as the Minority Judgment appears to do at, for example, [220]–[221], [226]–[227] and [268]–[269]). In our judgment, no reliance can or should be placed on the fact that Dr Saluja examined Roszaidi shortly after his arrest in 2015 for the purposes of answering this latter question. This fact is simply not relevant to that inquiry, especially because Dr Saluja was not at that time considering or addressing these questions to begin with.
- [51]
[51] Even more troubling is the fact that, even though Dr Saluja was given an opportunity to address the three limbs of the Nagaenthran test in his 2nd to 5th Reports, which were prepared after we specifically directed the parties to address those issues in Azli, he added little of value to his initial analysis for the purposes of s 33B of the MDA, and essentially maintained his earlier overall assessment that Roszaidi’s mental condition did not contribute to his offence. These subsequent reports were each only a page long and were utterly lacking in rigour and substantiation. We illustrate this by setting out the relevant excerpts of Dr Saluja’s 2nd and 3rd Reports, where he made no demonstrable attempt to properly consider the specific questions posed to him or to substantiate the reasons for his opinions:
- [52]
[52] Dr Saluja’s 4th and 5th Reports suffered from similar as well as other shortcomings, which we deal with in more detail at [142] below. We also note that no further reports were produced by Dr Saluja for the specific purposes of the remittal hearing.
- [53]
[53] Placing weight on Dr Saluja’s reports would therefore be, with respect, problematic. Dr Saluja began in his 1st Report by addressing his mind to the distinct issues of unsoundness of mind and fitness to plead; he had little to say regarding the new issues that arose when s 33B of the MDA was put in issue by CM 17, and which are central to the present appeal; and he seemed to have carried the conclusions he reached in relation to his earlier analysis over to the later inquiry he was required to undertake following CM 17, even though the relevant questions and thresholds were fundamentally different. There is the additional difficulty that all Dr Saluja did in these reports was to present his conclusions. An expert report, whether tendered for the Prosecution or for the Defence, that states conclusions without reasons, and which cannot be probed or evaluated, is simply of no value as expert evidence: see Pacific Recreation Pte Ltd v S Y Technology Inc and another appeal [2008] 2 SLR(R) 491 at [85] and Public Prosecutor v Chia Kee Chen and another appeal [2018] 2 SLR 249 at [118]–[119]. This renders it untenable to rely on any of Dr Saluja’s reports for the purposes of answering the questions before us in this appeal.
- [54]
[54] Dr Rajesh’s reports, in contrast, were all directed at addressing the limbs of the Nagaenthran test: Dr Rajesh’s 1st Report was produced in response to our directions before hearing the appeals in Azli, and Dr Rajesh’s 2nd and 3rd Reports were produced for the purpose of the remittal hearing, to address the issues that we remitted to the Judge (see [32]–[35] above). Moreover, although Dr Rajesh’s 1st Report was prepared primarily based on Dr Saluja’s 1st to 4th Reports and testimony at trial, Dr Rajesh’s 2nd Report was also prepared with reference to four interviews with Roszaidi that he conducted in October and November 2019 and the statements given by Roszaidi to the police after his arrest. Thereafter, Dr Rajesh’s 3rd Report was prepared with reference to further interviews he conducted with Roszaidi, his wife and his brother in August 2020. Although these interviews took place four years after the commission of the offence, they had the advantage of being targeted at addressing the remitted questions. In the circumstances, it seems clear to us that Dr Rajesh’s analysis of the facts presents a more complete, more targeted and, ultimately, more relevant view than Dr Saluja’s.
- [55]
[55] It must also be borne in mind that because Dr Rajesh first personally examined Roszaidi only in October 2019, he could not possibly have made any firm findings on, or any concrete diagnosis of, Roszaidi’s condition at the material time in 2015. Dr Rajesh’s reports could only consider, as they did, whether what he knew about Roszaidi’s state at the material times was consistent with the themes and findings identified in the literature. Dr Rajesh’s approach in this regard thus cannot be held against either him or Roszaidi. On the other hand, in a sense, Dr Rajesh had more sources of information about Roszaidi to rely on in preparing his reports than Dr Saluja did. He had the benefit of the information recorded in Dr Saluja’s 1st Report and the other contemporaneous evidence, such as the hospital discharge summaries and case notes for Roszaidi, as well as the statements given by Roszaidi after his arrest (for the purposes of Dr Rajesh’s 2nd Report). These were then supplemented by Dr Rajesh’s own interviews with Roszaidi, his wife and his brother in 2019 and 2020.
- [56]
[56] With that in mind, we turn to address the first issue outlined at [46(a)] above: whether the Second Limb of the Nagaenthran test is satisfied in the present case.
The Second Limb of the Nagaenthran test
The applicable principles
- [57]
[57] At the Second Limb of the Nagaenthran test, the question that arises for the court’s determination is whether the relevant abnormality of mind: (a) arose from a condition of arrested or retarded development of mind; (b) arose from any inherent causes; or (c) was induced by disease or injury. This is largely a matter for expert evidence (see Nagaenthran at [32]). The onus lies on the accused person to identify which of the prescribed aetiologies is applicable in his case (see Iskandar bin Rahmat v Public Prosecutor and other matters [2017] 1 SLR 505 (“Iskandar”) at [89]). Of these three aetiologies, the one principally in issue is the second – whether the abnormality of mind in question arose from an inherent cause.
- [58]
[58] It has been held that these prescribed aetiologies ought to be read restrictively rather than extensively (see Nagaenthran at [31]). However, to understand precisely what such an approach entails, it is useful to consider what kinds of abnormalities of mind would not be regarded as falling within the scope of these aetiologies. In Nagaenthran at [31], we held that Parliament had not intended for s 33B(3)(b) of the MDA to apply to accused persons suffering from “transient or even self-induced illnesses that have no firm basis in an established psychiatric condition” [emphasis added] that arose from one or more of these three aetiologies. In this regard, we noted that in introducing s 33B(3)(b), the Minister had stated that it was “not [their] intention to extend this to those who do not suffer from a recognised and proven psychiatric condition” (Singapore Parliamentary Debates, Official Report (14 November 2012) vol 89 (“14 November 2012 Debates”) at p 1236 (K Shanmugam, Minister for Foreign Affairs and Minister for Law (“Mr Shanmugam”))).
- [59]
[59] The background to the introduction of s 2(1) of the Homicide Act 1957 (c 11) (UK) is also instructive, as the wording of the prescribed aetiologies in that provision (in the context of homicide) is identical to that in s 33B(3)(b) of the MDA. As we observed in Iskandar at [85] and [87] (and Nagaenthran at [30]), at the Second Reading of the relevant Bill, the English Home Secretary stressed that the defence was only intended to cover those grave forms of abnormality of mind that might substantially impair responsibility, and was not intended to provide a defence to persons who were merely hot-tempered, or who, while otherwise normal, might commit murder in a sudden excess of rage or jealousy (see House of Commons, Parliamentary Debates (15 November 1956) vol 560). In the same vein, as we noted in Iskandar at [87] and Nagaenthran at [30], the purpose behind the reference to these specific aetiologies in s 304A of the Criminal Code (Qld) (again in the context of homicide) was described by the Queensland Court of Criminal Appeal in R v Whitworth [1989] 1 Qd R 437 (“R v Whitworth”) at 451–452 in the following terms (per Derrington J):
- [60]
[60] In our judgment, what emerges from this is that the primary concern underlying the restrictive reading of the aetiologies prescribed in the Second Limb is the need to limit the application of s 33B(3)(b) of the MDA to accused persons suffering from recognised and established psychiatric conditions, and to exclude abnormalities of the mind that arise from other sources such as heightened states of emotion or intoxication that are not beyond the accused person’s control. Indeed, as reflected in the unanimous view of this court in Iskandar at [89], the wording of the prescribed aetiologies appears “wide enough to include most recognised medical conditions”.
Whether the Second Limb is satisfied by Roszaidi’s MDD and SUD operating together
- [61]
[61] With these principles in mind, we turn to consider whether the Second Limb is satisfied on the facts of the present case. Given that it is undisputed that Roszaidi’s MDD arose from an inherent cause, what remains to be decided is whether the Second Limb is satisfied by Roszaidi’s MDD and his SUD operating together. In the circumstances of the present case, this turns on whether Dr Rajesh’s Synergy Claim – that Roszaidi’s MDD and SUD operated in a “synergistic” manner – ought to be accepted, such that they both arose from the same inherent cause.
- [62]
[62] The Judge preferred Dr Saluja’s evidence in this regard and rejected Dr Rajesh’s Synergy Claim. The Judge found that there was “no evidence” that Roszaidi’s MDD and SUD had operated in such a synergistic manner or that the existence of Roszaidi’s SUD was contingent on his MDD, noting that Roszaidi had a “long-standing history of dependence on multiple substances” but only started exhibiting symptoms of MDD around seven months before his arrest (see the Remittal Judgment at [8]–[9]). We observe that this seems to misunderstand Roszaidi’s primary argument. His case is not that his SUD was contingent on or brought about by his MDD. On the contrary, his case is that when his MDD set in, it significantly exacerbated the gravity and effects of his SUD in a way that made it wholly artificial and indeed impossible to segregate the two.
- [63]
[63] It is well established that “[a]n appellate court will be slow to criticise without good reason a trial court’s findings on expert evidence”. However, if the appellate court “entertains doubts as to whether the evidence has been satisfactorily sifted or assessed by the trial court”, it may “embark on its own critical evaluation of the evidence focussing on obvious errors of fact and/or deficiencies in the reasoning process”. It bears emphasis that evidence “must invariably be sifted, weighed and evaluated in the context of the factual matrix and in particular, the objective facts” (Sakthivel Punithavathi v Public Prosecutor [2007] 2 SLR(R) 983 at [74] and [76]). In our view, the Judge erred in holding that the Second Limb was not satisfied, as Dr Rajesh’s Synergy Claim is borne out on the evidence before us. In other words, Roszaidi’s MDD formed the “underlying substrate” for exacerbating his SUD and the two recognised psychiatric conditions operated in a “synergistic” manner to affect Roszaidi’s mental state. We elaborate on this view with reference to the evidence of each expert on the severity of Roszaidi’s MDD and its impact on his SUD, as well as with reference to the objective facts.
Dr Saluja’s evidence
- [64]
[64] With regard to the severity of Roszaidi’s MDD, Dr Saluja opined that Roszaidi’s MDD was mild, and that the symptoms of a mild depressive episode were “not significant enough to … significantly disturb one’s functioning”. We are unable to accept this assessment.
- [65]
[65] We note at the outset that Dr Saluja’s opinion on this point was raised for the first time during his examination-in-chief at the remittal hearing. As explained at [51] above, Dr Saluja was given ample opportunity to address this point fully in his 2nd to 5th Reports, which were all prepared after we specifically directed the parties to adduce additional psychiatric evidence addressing the three limbs of the Nagaenthran test. However, notwithstanding this, these further reports by Dr Saluja were of limited utility for the reasons set out at [51]–[53] above, and in none of them did he venture to state – much less substantiate – his assessment of the severity of Roszaidi’s MDD. Dr Saluja also did not produce any further reports for the specific purposes of the remittal hearing.
- [66]
[66] More fundamentally, the problem with Dr Saluja’s assessment is that it was expressly based on the fact that Roszaidi only exhibited four to five symptoms in the diagnostic manual International Statistical Classification of Diseases and Related Health Problems: 10th revision (World Health Organization, 5th Ed, 2016) (“ICD-10”), and at least four symptoms were needed for a patient to qualify for a depressive episode. Based on the general qualifiers for the diagnosis of MDD, Dr Saluja then concluded that Roszaidi’s depressive symptoms were not a contributory factor to the alleged offence because “even in the mild depressive episode category, the symptoms are not significant enough to … significantly disturb one’s functioning”, and “generally, the effects of mild depressive symptoms are mild, when people are able to function to some extent”.
- [67]
[67] Turning to the impact of Roszaidi’s MDD on his SUD. Dr Saluja opined that Roszaidi’s MDD did not affect his will to resist the urge to consume and traffic drugs; only his SUD did. In his words, Roszaidi’s “[i]nability to resist using drugs [was] a part of [his] drug dependence, not part of [a] depressive episode”. On this basis, Dr Saluja took the position that Roszaidi’s MDD did not even contribute to his ability or inability to resist drug-seeking behaviour. In coming to this view, Dr Saluja failed to take into account the interaction between the two disorders – an omission that is particularly glaring in view of Dr Saluja’s own observations. Dr Saluja’s clinical notes dated 26 October 2015 (“Dr Saluja’s Clinical Notes”) recorded that Roszaidi was depressed after his loved ones passed away in May 2015 and so he “just took [drugs] whenever [he] felt low”. Similarly, Dr Saluja’s 1st Report recorded that Roszaidi had been “feeling stressed and depressed” for the past seven months since his bereavements, and that he subsequently lost his job which “added to his financial problems”. Against this background, he consumed dormicum, heroin and ice to “reduce his stress”. This, in essence, was part of the Synergy Claim, which – though reflected in Dr Saluja’s Clinical Notes and 1st Report – was nonetheless rejected by him without a clear or sensible explanation. Dr Saluja’s stated position that Roszaidi’s MDD did not affect his ability to resist drug-seeking behaviour is also factually contradicted by the escalation in Roszaidi’s drug consumption around and after the onset of his MDD in May 2015 (see [20] above). Indeed, the inference that Roszaidi’s MDD went hand-in-hand with his SUD arises even more strongly from Dr Saluja’s own account that Roszaidi’s drug consumption resumed in or around May 2015 after a relatively long period of remaining drug-free in the community, instead of just escalating at that time from an already existing level of consumption (see [18] above). The synergistic operation of Roszaidi’s MDD and SUD is thus reflected not only in Dr Rajesh’s expert evidence (which we come to next), but also indirectly in Dr Saluja’s own evidence, as well as in the objective facts which are – so far as material – not disputed by either expert.
Dr Rajesh’s evidence
- [69]
[69] We turn to Dr Rajesh’s evidence. Dr Rajesh did not expressly comment on the severity of Roszaidi’s MDD, and was not asked to comment on the “quantitative” analysis adopted by Dr Saluja in assessing the severity of Roszaidi’s MDD. However, he did not downplay the severity or impact of the MDD, either on Roszaidi’s mental state generally or on Roszaidi’s SUD. Dr Rajesh took the view that Roszaidi’s MDD aggravated his SUD and that, as a result, the two conditions operated in a “synergistic” manner making it impossible and unrealistic to consider each on its own (in other words, the Synergy Claim). In Dr Rajesh’s 1st and 2nd Reports, he opined that Roszaidi’s “multiple substance abuse [was] exacerbated in the context of his underlying [MDD] in the few months prior to the offence”, noting that it was common for depressed people to consume drugs as a form of self-medication for their depressive symptoms – a phenomenon described in the psychiatric scientific literature as a “dual diagnosis”. This was elaborated on in Dr Rajesh’s examination-in-chief at the remittal hearing, where he stated that Roszaidi’s MDD was “the underlying substrate for his escalating drug abuse” and he specifically noted that Roszaidi was using drugs on a daily basis to cope with his depression. His MDD and SUD thus played a “synergistic role” and “contributed to each other at the material time”. We digress to note that this was precisely in line with Dr Saluja’s evidence that Roszaidi would take drugs “whenever [he] felt low” after the bereavements.
- [70]
[70] Dr Rajesh pointed to clinical literature to substantiate his opinions on the relationship between MDD and SUD. Whereas Dr Saluja simply asserted that only Roszaidi’s SUD (and not his MDD) contributed to his inability to resist drug-seeking behaviour (see [67] above), Dr Rajesh referred to a scientific paper published in JAMA Psychiatry (a peer-reviewed medical journal published by the American Medical Association) in January 2016 which had found “[s]ignificant associations” between MDD and 12-month drug use disorders (Bridget F Grant, et al, “Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III” (2016) 73(1) JAMA Psychiatry 39).
- [71]
[71] Critically, Dr Rajesh’s Synergy Claim is borne out by the objective facts. Roszaidi had largely abstained from drugs for over a year after his release from prison in 2014, but it is common ground between the experts that Roszaidi’s drug consumption either recommenced or escalated after he suffered the two bereavements in May 2015 that triggered his MDD (see [18]–[20] above). Against this factual background, as well as the interviews Dr Rajesh had conducted with Roszaidi (see [54] above), Dr Rajesh’s 2nd Report noted that Roszaidi began “consuming drugs excessively as a means of coping with his symptoms of depression” at the time. Similarly, Dr Rajesh’s 3rd Report recorded that Roszaidi’s consumption of drugs increased following these two bereavements, that “ice and heroin improved his mood and gave him energy”, and that “the combination of cannabis and heroin used to make him feel good and made him forget the pain of the past”. During his cross-examination, Dr Rajesh elaborated on his point regarding drug consumption as a form of self-medication for symptoms of depression, in relation to Roszaidi specifically, by stating that “the drugs were being used to … cope with these symptoms of depression because he never sought treatment from a psychiatrist or a psychologist”. Dr Rajesh’s Synergy Claim thus not only coheres with the general scientific literature, but is also grounded in the specific factual circumstances of Roszaidi’s case. This reinforces our view (stated at [55] above) that Dr Rajesh did in fact consider – as far as was possible, given that he was only able to examine Roszaidi years after the event – the specific circumstances of Roszaidi’s case in drawing his conclusions on how the general themes and findings derived from the scientific literature would apply to Roszaidi.
Further observations
- [72]
[72] We note at this juncture that the degree of escalation in Roszaidi’s drug consumption, following the two bereavements and the onset of his MDD in May 2015, is not in evidence. This was acknowledged by Mr Thuraisingam at the hearing of the appeal. Nevertheless, we do not think that this weighs against Roszaidi in the present case.
- [73]
[73] It is important to highlight that Roszaidi’s rate of drug consumption was not a live issue at trial. Indeed, as we have noted at [30]–[31] above, the question of whether Roszaidi satisfied the conditions for re-sentencing under s 33B(1)(b) of the MDA was not raised at trial and was only put in issue by and after the disposal of CM 17. In the remitted proceedings below, both the Judge and the parties appear to have proceeded on the basis that the scope of the remittal would effectively be confined to the psychiatric evidence. In remitting the matter to the Judge, we noted that “the evidence that would have been relevant for the consideration of the issues under s 33B(3) – particularly, the psychiatric evidence which would be crucial under s 33B(3)(b) – was uneven”, and that the case would be remitted to the Judge “for further psychiatric evidence to be taken” (Azli at [25]; see also Azli at [32], stating that there was “good reason to take additional psychiatric evidence” on Roszaidi’s mental state at the time of the offence). Although, at [40] of Azli, we referred more broadly to the questions being remitted to the Judge “for additional evidence to be taken pursuant to s 392(1) of the CPC”, the preceding discussion had centred around the psychiatric reports produced by Dr Saluja and Dr Rajesh leading up to the hearing of that appeal. When submissions were later made to the Judge on the preliminary issue of the scope of the remitted inquiry, Mr Thuraisingam submitted on Roszaidi’s behalf that the Judge should permit evidence to be taken not only from Dr Saluja and Dr Rajesh, but also from Roszaidi himself, and his wife and younger brother. However, the Judge directed that Dr Saluja and Dr Rajesh’s evidence would be heard first, and the court “may give further directions” after hearing that expert evidence. In the event, no such directions were given or sought on the calling of these lay witnesses, including Roszaidi himself.
- [74]
[74] In these circumstances, it seems to us that Roszaidi did not have the opportunity to give direct evidence on his rate of drug consumption when this became a live issue. It appears that Roszaidi initially took the position that he did wish to give evidence, even though this point was not pursued further after the Judge’s initial direction that the expert evidence would be heard first with further directions to follow. We are therefore bound to consider the issue of Roszaidi’s escalating drug consumption on the basis of the expert evidence before us, and we do not hold against Roszaidi the absence of his direct evidence on the degree of escalation in his drug consumption following the bereavements. We add that any doubt when assessing the evidence as a whole in this context should in fairness be resolved in Roszaidi’s favour, because he had initially expressed a desire, but ultimately had no opportunity, to give evidence that might have turned out to be relevant to the remitted issues.
- [75]
[75] In this regard, we should highlight some important points of difference between our views and those of the minority. From [233]–[241] of the Minority Judgment, it will be seen that the minority essentially takes issue with Roszaidi’s evidential case on three points. First, that Roszaidi has not adduced evidence of the degree of escalation of his drug use following the onset of his MDD in May 2015. Second, that, even if he had adduced evidence to prove the escalation in his drug use following the onset of his MDD, he has failed to establish a causal link between such escalation and his MDD. Third, that the dearth of evidence as to these issues is largely a consequence of the manner and stage at which Roszaidi sought to rely on the alternative sentencing regime under s 33B(3)(b) of the MDA.
- [76]
[76] With respect, we do not agree with any of these objections for three reasons.
(a) First, as stated above, although Mr Thuraisingam did not pursue Roszaidi’s intention to testify at the remittal hearing after Dr Saluja and Dr Rajesh had given their evidence, Roszaidi did initially take the position that he wished to give evidence. We do not think it appropriate – particularly in a capital case – to hold against Roszaidi his counsel’s and the Judge’s failure to return to the issue.
(b) Second, in any event, we do not agree with the minority’s view that there is insufficient evidence to establish Roszaidi’s escalated drug use, the degree of such escalation and that this was connected to the onset of his MDD. On the one hand, based on Dr Saluja’s 1st Report (on which the minority relies substantially in arriving at its conclusions), Roszaidi was drug-free for around a year and a half before he started consuming drugs again in May 2015 (see [18] above). That he went from no consumption back to consumption after remaining off drugs for this relatively substantial period is patently evidence of escalation. An increase from a nil to positive position is, quite simply, escalation. On the other hand, if we instead rely on Dr Rajesh’s 2nd Report, we see that Roszaidi’s consumption increased in May 2015 after the bereavements even though his consumption started earlier in February 2015. So this, too, is evidence of escalation. At [236]–[237] of the Minority Judgment, the minority seems to require Roszaidi to establish that his consumption restarted only after the bereavements. However, with respect, we cannot agree. Roszaidi’s task is to prove that his drug use escalated after the onset of his MDD such that it can be said that both his SUD and his MDD arose from the same inherent cause (meaning the Synergy Claim) so as to satisfy the Second Limb of the Nagaenthran test (see [62] above). He does not need to establish that his drug use only restarted after the bereavements.
(c) Third, Roszaidi need only prove on a balance of probabilities that the escalation in his consumption, be it an escalation from no consumption on Dr Saluja’s evidence or from some consumption on Dr Rajesh’s, was caused by his MDD. On either expert’s account, such escalation coincided with the bereavements. In our judgment, this objective fact coheres with and strengthens Dr Rajesh’s view as to the synergistic operation of the two disorders affecting Roszaidi, and the absence of evidence of the degree of escalation does not then undermine this in the circumstances of this case. In any event, the fact of the escalation would shift the evidential burden back to the Prosecution to disprove the connection. That the escalation in Roszaidi’s drug use and the bereavements were temporally aligned, even on Dr Saluja’s account, should not and cannot be written off as mere coincidence or happenstance just because Roszaidi had been a drug user for most of his life (an analytical approach implicitly taken by the minority: see [238] of the Minority Judgment). This is particularly so when viewed against the backdrop of the relatively long drug-free period Roszaidi managed to maintain after being released from prison in 2014.
Thus, for these reasons, the minority’s evidential concerns do not affect our conclusions in respect of the Second Limb of the Nagaenthran test.
- [77]
[77] Before setting out our conclusions on the Second Limb, however, we make a final observation. At the hearing before us, Mr Thuraisingam accepted that there was no other evidence of how Roszaidi’s MDD manifested other than his escalated drug consumption, because this issue was not taken up at the trial. However, what is in our view material is that there was ample evidence of this escalated drug consumption and this fact is accepted by the court. Given that the focus of the analysis under the Second Limb in this case is on the impact of Roszaidi's MDD on his SUD, and that escalated drug consumption is the key manifestation of Roszaidi’s MDD that we are concerned with in the present context, the fact that other manifestations were not fully explored does not seem to us to be pertinent and so makes no difference to our conclusion on this point.
Conclusion on the Second Limb
- [78]
[78] For the reasons set out above, we are satisfied that Roszaidi’s MDD and SUD operated together in a “synergistic” manner, and that his MDD formed the “underlying substrate” for his SUD such that it accounted for the intensity at which his SUD operated at the time of the offence. Both Dr Saluja and Dr Rajesh recognise, in substance, that Roszaidi used drugs to cope with the depressive symptoms triggered by the passing of his mother and grandmother; and, further, this is borne out by the fact that the escalation in Roszaidi’s drug consumption in the months before the offence dovetailed with the onset of his MDD following these bereavements. In the circumstances of the present case, the evidence indicates that Roszaidi’s MDD and SUD were inextricably intertwined at the material time, such that it would be impractical and artificial to attempt to ascertain the aetiology of Roszaidi’s SUD in isolation from his MDD.
- [79]
[79] Accordingly, we hold that the Judge erred in rejecting Dr Rajesh’s Synergy Claim and finding, on that basis, that the Second Limb was not satisfied. Given that it is undisputed that Roszaidi’s MDD arose from an inherent cause, this leads us to the conclusion that Roszaidi’s SUD also arose from an inherent cause. Although neither expert gave evidence that Roszaidi’s SUD itself arose from any of the prescribed aetiologies in s 33B(3)(b) of the MDA, the interaction between Roszaidi’s MDD and SUD in the circumstances of the present case allows us to conclude that the Second Limb is satisfied by both conditions operating together at the material time.
The judgment continues past this page. Read the rest at eLitigation.